| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1100160870 |
| P356 | DOI | 10.1186/S13039-017-0348-Y |
| P932 | PMC publication ID | 5753467 |
| P698 | PubMed publication ID | 29308088 |
| P50 | author | Jeremy A. Squire | Q39802515 |
| P2093 | author name string | Daniel Guimarães Tiezzi | |
| Jeremy A. Squire | |||
| Thiago Vidotto | |||
| P2860 | cites work | The DNA sequence and comparative analysis of human chromosome 20 | Q21735926 |
| Mechanisms of change in gene copy number | Q22122003 | ||
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Mutational heterogeneity in cancer and the search for new cancer-associated genes | Q24606956 | ||
| Genetic variation and the de novo assembly of human genomes | Q26786788 | ||
| FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome. | Q27851411 | ||
| FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome | Q28235519 | ||
| Essential role for nuclear PTEN in maintaining chromosomal integrity | Q28513781 | ||
| Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size | Q29544005 | ||
| Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data | Q30872480 | ||
| Small deletion variants have stable breakpoints commonly associated with alu elements. | Q33366520 | ||
| Recurrent hemizygous deletions in cancers may optimize proliferative potential | Q33637152 | ||
| Clinical outcomes and correlates of TP53 mutations and cancer | Q33693838 | ||
| Interleukin-17 promotes development of castration-resistant prostate cancer potentially through creating an immunotolerant and pro-angiogenic tumor microenvironment | Q33777002 | ||
| Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment | Q33852664 | ||
| PTEN C-terminal deletion causes genomic instability and tumor development | Q33874805 | ||
| Homologous recombination as a mechanism for genome rearrangements: environmental and genetic effects | Q34045894 | ||
| Evidence for molecular differences in prostate cancer between African American and Caucasian men | Q34205227 | ||
| PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity | Q34484407 | ||
| The Molecular Taxonomy of Primary Prostate Cancer | Q34674332 | ||
| Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway | Q35001678 | ||
| Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations | Q35597950 | ||
| Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancer | Q35854235 | ||
| MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma | Q36605100 | ||
| Mutational Landscape of Aggressive Prostate Tumors in African American Men | Q36633535 | ||
| Recurrent deletions and reciprocal duplications of 10q11.21q11.23 including CHAT and SLC18A3 are likely mediated by complex low-copy repeats | Q36848387 | ||
| Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer. | Q36959119 | ||
| When Genome Maintenance Goes Badly Awry | Q37138583 | ||
| Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress | Q37380066 | ||
| Germline and somatic KLLN alterations in breast cancer dysregulate G2 arrest | Q37380558 | ||
| The cancer biology of whole-chromosome instability. | Q38074016 | ||
| PTEN function: the long and the short of it. | Q38198345 | ||
| High-risk prostate cancer: a disease of genomic instability | Q38220416 | ||
| Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. | Q38311815 | ||
| DNA replication stress as a hallmark of cancer | Q38332707 | ||
| Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer | Q38717692 | ||
| Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH. | Q38833458 | ||
| DNA damage signalling barrier, oxidative stress and treatment-relevant DNA repair factor alterations during progression of human prostate cancer | Q38893748 | ||
| Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical Prostatectomy | Q39540003 | ||
| Androgen deprivation leads to increased carbohydrate metabolism and hexokinase 2-mediated survival in Pten/Tp53-deficient prostate cancer | Q39634850 | ||
| The Identification of Microdeletion and Reciprocal Microduplication in 22q11.2 Using High-Resolution CMA Technology | Q40140280 | ||
| In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in situ hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading | Q40919195 | ||
| A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer | Q40978920 | ||
| Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome | Q41870312 | ||
| Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERG. | Q42356687 | ||
| Repetitive DNA in eukaryotic genomes. | Q42654883 | ||
| PTEN loss in biopsy tissue predicts poor clinical outcomes in prostate cancer | Q45251986 | ||
| Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer | Q46975204 | ||
| PTEN in the maintenance of genome integrity: From DNA replication to chromosome segregation | Q50168053 | ||
| Genomic hallmarks of localized, non-indolent prostate cancer. | Q50211176 | ||
| A Single-Nucleotide Substitution Mutator Phenotype Revealed by Exome Sequencing of Human Colon Adenomas | Q57161434 | ||
| PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications | Q57790325 | ||
| Chromothripsis as a mechanism driving complex de novo structural rearrangements in the germline† | Q63432946 | ||
| ThePTEN gene in locally progressive prostate cancer is preferentially inactivated by bi-allelic gene deletion | Q63966367 | ||
| Targeted inactivation of p53 in human cells does not result in aneuploidy | Q77678749 | ||
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P304 | page(s) | 1 | |
| P577 | publication date | 2018-01-03 | |
| P1433 | published in | Molecular Cytogenetics | Q15761790 |
| P1476 | title | Distinct subtypes of genomic PTEN deletion size influence the landscape of aneuploidy and outcome in prostate cancer | |
| P478 | volume | 11 |
| Q92445464 | Detection and Correlation of Single and Concomitant TP53, PTEN, and CDKN2A Alterations in Gliomas |
| Q93196102 | Emerging role of PTEN loss in evasion of the immune response to tumours |
| Q93046038 | Identifying small molecule probes of ENTPD5 through high throughput screening |
| Q92702101 | PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise? |
| Q52723228 | Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas. |
| Q55323049 | Understanding aneuploidy in cancer through the lens of system inheritance, fuzzy inheritance and emergence of new genome systems. |
Search more.